Inogen: Sustained Revenue Momentum, Margin Expansion, and New Product Pipeline Underpin Buy Rating
TipRanks (Wed, 25-Feb 5:35 AM ET)
Inogen outlines path to 6% revenue growth in 2026 while launching $30M share repurchase program
Seeking Alpha News (Tue, 24-Feb 9:08 PM ET)
Inogen Posts 2025 Results and Launches Share Buyback
TipRanks (Tue, 24-Feb 4:40 PM ET)
Inogen GAAP EPS of -$0.26 beats by $0.09, revenue of $81.7M misses by $0.3M
Seeking Alpha News (Tue, 24-Feb 4:23 PM ET)
Inogen authorizes $30M share repurchase program; shares up
Seeking Alpha News (Tue, 24-Feb 4:12 PM ET)
Business Wire (Tue, 24-Feb 4:05 PM ET)
Inogen Announces $30 Million Share Repurchase Program
Business Wire (Tue, 24-Feb 4:00 PM ET)
Here are the major earnings after the close Tuesday
Seeking Alpha News (Tue, 24-Feb 10:00 AM ET)
Here are the major earnings before the open Tuesday
Seeking Alpha News (Mon, 23-Feb 6:00 PM ET)
Inogen Q4 2025 Earnings Preview
Seeking Alpha News (Mon, 23-Feb 5:35 PM ET)
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.
Inogen trades on the NASDAQ stock market under the symbol INGN.
As of February 25, 2026, INGN stock price climbed to $6.01 with 1,017,227 million shares trading.
INGN has a beta of 0.93, meaning it tends to be less sensitive to market movements. INGN has a correlation of 0.12 to the broad based SPY ETF.
INGN has a market cap of $163.16 million. This is considered a Micro Cap stock.
Last quarter Inogen reported $82 million in Revenue and -$.15 earnings per share. This fell short of revenue expectation by $-279,000 and exceeded earnings estimates by $.10.
In the last 3 years, INGN traded as high as $16.98 and as low as $4.13.
The top ETF exchange traded funds that INGN belongs to (by Net Assets): VTI, IWM, VXF, IWN, VTWO.
INGN has underperformed the market in the last year with a return of -38.9%, while the SPY ETF gained +17.3%. In the last 3 month period, INGN fell short of the market, returning -15.1%, while SPY returned +3.9%. However, in the most recent 2 weeks INGN has outperformed the stock market by returning +4.5%, while SPY returned +0.1%.
INGN support price is $5.66 and resistance is $6.03 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that INGN shares will trade within this expected range on the day.